Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Eur Respir J. 2017 Sep 11;50(3):1700537. doi: 10.1183/13993003.00537-2017

Table 1.

Baseline characteristics of participants in AGES-Reykjavik and COPDGene stratified by ILA status and race.*

AGES-Reykjavik P-value COPDGene Non-Hispanic Whites P-value COPDGene African-Americans P-value
No ILA
(N=3209)
ILA
(N=377)
No ILA
(N=3667)
ILA
(N=485)
No ILA
(N=1728)
ILA
(N=223)
Age – yrs 76 ± 5 78 ± 6 <.0001 61 ± 9 64 ± 10 <.0001 54 ± 7 55 ± 8 0.003
Gender – no. female(%) 1905 (59) 171 (45) <.0001 1752 (48) 219 (45) 0.29 705 (41) 126 (57) <.0001
Body Mass Index 27 ± 4 27 ± 5 0.50 29 ± 6 29 ± 6 0.25 29 ± 7 29 ± 7 0.33
Pack Years Smoking, median (IQR) 2
(0, 25)
20
(0, 50)
<.0001 40
(29, 56)
45
(34, 63)
<.0001 34
(22, 46)
35
(24, 47)
0.49
Current Smokers – no. yes (%) 373 (12) 69 (18) 0.0003 1402 (38) 2546 (53) <.0001 1393 (81) 183 (82) 0.65
History of COPD§ – no. (%) 1474 (40) 167 (35) 0.02 381 (22) 54 (25) 0.44
Percentage of the lung less than −950 Hounsfield Units, median (IQR) 3
(0.9, 9)
1.4
(0.5, 4.8)
<.0001 1.1
(0.4, 3.3)
0.7
(0.2, 2.4)
<.0001
*

ILA is interstitial lung abnormality, ± values are means and standard deviations.

IQR is interquartile range

Includes cigarette and cigar smoking

§

COPD is chronic obstructive pulmonary disease